Core Viewpoint - Meinian Health's stock price closed at 5.04 yuan on July 30, 2025, reflecting a decline of 1.18% from the previous trading day, with a trading volume of 4.35 billion yuan [1] Company Overview - Meinian Health operates in the healthcare services industry, specializing in health check-ups and medical services, including health examinations, health management, and medical consulting [1] Recent Developments - The company has recently received a new business license from the Zhejiang Provincial Market Supervision Administration, following the approval of related amendments by the board of directors and the shareholders' meeting [1] Financial Activity - On July 30, the net inflow of main funds into Meinian Health was 193,400 yuan [1]

Group 1 - The company announced the convening of the 10th (temporary) meeting of the 9th Board of Directors on July 11, 2025, and the first temporary shareholders' meeting on July 28, 2025, to review the proposal for amendments [2] - The company has recently received a new business license issued by the Zhejiang Provincial Market Supervision Administration [2]

一篇《女律师十年体检未有"患癌风险"预警，确诊已是肾癌晚期》的文章，正在将体检行业龙头爱康国宾拖入舆论的风暴，而这场风波也再次让公众对整 个民营体检行业守护健康的价值，产生严重的质疑。 舆论压力之下，爱康国宾在7月30日举行了媒体说明会。 而爱康集团创始人、董事长兼CEO张黎刚对此称，"大家想一下，大多数企业给员工做个体检，少的几百块，钱多的也就几千块钱，大家去医院看个病， 你要诊断某个病，你们问问自己，大概要花多少钱。当你指望说，一个几百块钱的体检能帮你什么病都查出来，而要查单一的病，多花几千几万块钱的时 候，你认为这样的情况存在吗?至于这样的模糊的原因，就是因为我们公众对于体检与看病，没有明确的边界，导致公众对体检有很多误解。" 此番回应，不仅让爱康国宾陷入巨大争议，更是再度将民营体检行业推上了口碑近乎崩盘的风口浪尖。 回到事件本身。从2013 年到 2023 年，女律师张晓玲在爱康国宾完成了十年体检，所有报告均显示 "正常"。直到 2024 年，她在其他医院被确诊癌症晚 期，历经九个月跨国治疗，付出了失去一个肾和腰椎终"右肾钙化灶"。回想2023年那次体检，张女士的报告已经提示了右肾钙化，她特意询问工作 ...

近日，公司收到浙江省市场监督管理局换发的《营业执照》。变更后公司登记 备案的相关信息如下： 名称：美年大健康产业控股股份有限公司 类型：股份有限公司（上市） 住所：浙江省绍兴市柯桥区华舍街道中纺时代大厦 0112 室 证券代码：002044 证券简称：美年健康 公告编号：2025-054 美年大健康产业控股股份有限公司 关于公司完成工商变更登记的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 美年大健康产业控股股份有限公司（以下简称"公司"）于 2025 年 7 月 11 日 召开第九届董事会第十次（临时）会议及 2025 年 7 月 28 日召开 2025 年第一次临 时股东大会，审议通过《关于修订<公司章程>的议案》。详见公司在巨潮资讯网 （www.cninfo.com.cn）披露的《关于修订<公司章程>的公告》（公告编号：2025- 043）及《2025 年第一次临时股东大会决议公告》（公告编号：2025-052）。 经营范围：从事医疗技术专业领域内的技术开发、技术咨询、技术转让、技术 服务；投资管理；健康管理咨询（不得从事医疗活动、心理咨询）；设 ...

Core Viewpoint - The major shareholder of Meinian Health Industry Holdings Co., Ltd., Hangzhou Xintou Information Technology Co., Ltd., has reduced its stake in the company from 11.81% to 10.88% through a series of transactions between July 23 and July 28, 2025, involving a total of 36,579,778 shares [1]. Group 1 - Hangzhou Xintou Information Technology Co., Ltd. executed a reduction of its shareholding in Meinian Health, impacting its ownership percentage significantly [1]. - The reduction in shareholding was disclosed in a pre-announcement on May 6, 2025, indicating compliance with information disclosure obligations [1]. - The reduction of shares has reached a threshold of 1% of Meinian Health's total share capital [1].

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 美年大健康产业控股股份有限公司（以下简称"公司"、"美年健康"）5%以上股东杭州信投信息技术有 限公司（以下简称"杭州信投"）于2025年7月23日至7月28日期间内通过大宗交易及集中竞价交易方式累 计减持公司36,579,778股股份，减持后杭州信投及其一致行动人杭州灏月企业管理有限公司合计持有的 美年健康股份比例由11.81%减少至10.88%。 证券代码：002044 证券简称：美年健康 公告编号：2025-053 美年大健康产业控股股份有限公司 关于5%以上股东权益变动触及1%刻度的公告 公司股东杭州信投信息技术有限公司保证向本公司提供的信息内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 ■■ 特此公告。 美年大健康产业控股股份有限公司 董 事 会 二〇二五年七月三十日 公司于2025年5月6日在巨潮资讯网（www.cninfo.com.cn）披露了《关于5%以上股东减持股份的预披露 公告》（公告编号：2025-027）。近日，公司收到杭州信投出具的《关于所持 ...

美年健康5%以上股东减持公告要点解读 7月23日：大宗交易减持1,410.39万股 7月25日：大宗交易减持1,665.12万股 7月28日：集中竞价减持582.47万股 持股变化 •杭州信投：持股比例从3.79%降至2.86% •杭州信投及一致行动人杭州灏月：合计持股比例从11.81%降 至10.88% •一致行动人杭州灏月：持股比例维持8.02%不变 核心事项 股东减持：5%以上股东杭州信投于2025年7月23-28日期间减持美年健康股份，触及1%刻度。 减持详情 •减持股数：3,657.98万股，占总股本0.93% •减持方式：大宗交易+集中竞价交易 •减持时间： 其他要点 • 本次减持按照此前5月6日预披露的减持计划执行 • 减持计划尚未履行完毕 • 不影响公司控制权及持续 经营 ...

证券代码：002044 证券简称：美年健康 公告编号：2025-053 美年大健康产业控股股份有限公司 关于 5%以上股东权益变动触及 1%刻度的公告 公司股东杭州信投信息技术有限公司保证向本公司提供的信息内容真实、 准确、完整，没有虚假记载、误导性陈述或重大遗漏。 董 事 会 二〇二五年七月三十日 特别提示： 美年大健康产业控股股份有限公司（以下简称"公司"、"美年健康"）5%以上 股东杭州信投信息技术有限公司（以下简称"杭州信投"）于 2025 年 7 月 23 日至 7 月 28 日期间内通过大宗交易及集中竞价交易方式累计减持公司 36,579,778 股 股份，减持后杭州信投及其一致行动人杭州灏月企业管理有限公司合计持有的美 年健康股份比例由 11.81%减少至 10.88%。 公司于 2025 年 5 月 6 日在巨潮资讯网（www.cninfo.com.cn）披露了《关于 5%以上股东减持股份的预披露公告》（公告编号：2025-027）。近日，公司收到 杭州信投出具的《关于所持美年健康股份变动的通知》，其减持触及美年健康总 股本 1%的刻度。现将相关情况公告如下： | 1、基本情况 | | | | ...

Core Viewpoint - The legal opinion from Beijing Tianyuan Law Firm confirms that the procedures for the 2025 first extraordinary general meeting of shareholders of Meinian Onehealth Healthcare Holdings Co., Ltd. were conducted in compliance with relevant laws and regulations, ensuring the legitimacy of the meeting and its resolutions [2][3][27]. Group 1: Meeting Procedures - The meeting was convened by the company's ninth board of directors on July 11, 2025, and the notice was published on July 12, 2025, detailing the time, location, and agenda [4][5]. - The meeting utilized a combination of on-site and online voting, held on July 28, 2025, at the company's conference room in Shanghai [4][6]. Group 2: Attendance and Voting - A total of 921 participants attended the meeting, holding 1,277,900,984 shares, which represents 32.6474% of the total voting shares [5][6]. - The voting included 528,253,450 shares from on-site attendees, accounting for 13.4956% of total shares, and 749,647,534 shares from online voters, representing 19.1517% [5][6]. Group 3: Voting Results - The resolutions were passed with significant support, with 1,272,894,440 shares voting in favor, which is approximately 99.9996% of the votes cast [6][7]. - For the minority investors, 282,237,144 shares voted in favor, representing 98.2570% of their total voting shares [6][7]. - All resolutions requiring a two-thirds majority were successfully approved, demonstrating strong shareholder support [6][7][8].

Meeting Overview - The shareholders' meeting of Meinian Health Industry Holdings Co., Ltd. was held on July 28, 2025, with a total of 921 participants representing 1,277,900,984 shares, accounting for 32.6474% of the total shares [1] - The online voting took place from 9:15 AM to 3:00 PM on the same day, with 916 shareholders participating, representing 749,647,534 shares, or 19.1517% of the total shares [2] Voting Results - The meeting adopted resolutions with a significant majority, where 1,272,894,440 shares voted in favor, representing 99.6082% of the valid votes [2] - A total of 4,509,144 shares opposed the resolutions, accounting for 0.3529%, while 497,400 shares were abstained [2] Minority Shareholder Participation - Among the minority investors, 282,237,144 shares voted in favor, which is 98.2570% of the valid votes from minority shareholders [3] - The opposition from minority shareholders was 4,509,144 shares, representing 1.5698% [3] Related Party Transactions - The resolutions involved related party transactions, with specific shareholders, including Yu Rong and several asset management companies, abstaining from voting [3][4] - The voting results from non-related shareholders showed 738,065,801 shares in favor, which is 98.4550% of the valid votes [4] Detailed Voting Breakdown - The detailed voting results indicated that among non-related minority shareholders, 275,661,955 shares voted in favor, representing 95.9680% [4] - The opposition from this group was 11,086,633 shares, accounting for 3.8597% [4] Conclusion of Resolutions - All resolutions requiring a two-thirds majority from non-related shareholders were successfully passed according to the company's articles of association [4][5] - The resolutions included significant related party transactions, with the relevant shareholders abstaining from the voting process [5][6]